FYR Bio

We’re at AACR 2026 this week. FYR Bio is on-site to connect with teams advancing oncology drug development. Our EV-Omics platform supports stronger biomarker discovery and translational insight from blood-based signals. Email bd@fyr.bio to meet. #AACR2026 #Oncology

Heading to AACR 2026 next week? Meet the FYR Bio team. We’re looking forward to conversations on oncology drug development and how our EV-Omics platform can support biomarker discovery and translational research. Email bd@fyr.bio to connect. #AACR2026 #Oncology

Our platform drives real-world impact across #ClinicalDevelopment: early & accurate detection, treatment monitoring, patient stratification, and risk assessment. We make #PrecisionMedicine actionable. More: fyr.bio/wp-content/upl… #NeuroDiagnostics #Biomarkers

Advancing precision medicine isn’t just about data; it’s about making data actionable. We empower researchers to ask better questions and get better answers by delivering biologically relevant insights from blood-based signals. Meet with us: @fyrdiagnostics.com/?ismsaljsauthenabled=true" target="_blank" rel="nofollow noopener">outlook.office.com/book/fyrintrom…

February is #CancerPreventionMonth, a time to recognize the importance of awareness, prevention, early detection, and continued progress against #Cancer. We’re focused on generating clearer molecular insight from blood-based signals to support more informed research.

FYR appoints @BKZehentner as COO. She brings > 25 years of experience in precision medicine and operational leadership. She joins as we scale our EVO platform to unravel the complexity of disease mechanisms. Learn more: fyr.bio/fyr-bio-appoin…

Today on #WorldCancerDay, we honor the patients, caregivers, and scientists working to improve #Cancer outcomes. At FYR, we’re advancing precision medicine with our AI-enabled EV-Omics platform to support better biomarkers, smarter trials, and more informed research. #Oncology

Live from the 14th #Alzheimers & #Parkinsons Drug Development Summit! Make sure you stop by our booth (#11) to learn more about our work and connect with the FYR team!

Next week, we’ll be in Boston for the #Alzheimer’s & #Parkinson’s Drug Development Summit! Stop by our booth (#11) w/ @HerantisPharma to learn more about our work or book a meeting with the FYR team:  @fyrdiagnostics.com/?ismsaljsauthenabled=true" target="_blank" rel="nofollow noopener">outlook.office.com/book/fyrintrom…

FYR accelerates #Neurology R&D with our #AI-powered EV-Omics platform, translating EV protein & RNA data into insights that power #Biomarker discovery, patient stratification & smarter trial design, turning #Molecular data into precision for pharma. More bit.ly/4r8qqzH

Our CEO Chris Booth is attending #JPM26 and meeting w/ teams exploring stronger biomarker strategy and translational support. Our EVO Platform reveals disease biology with precision—advancing #Biomarker discovery, tracking & validation. Meet with us: bit.ly/3LIJwNF

Heading to #JPM26 in San Francisco? FYR CEO Dr. Chris Booth will be on site and available to connect. Together, we can advance #PrecisionMedicine and drug development, turning insights into transformative solutions for patients. 📩 Meet with us: bd@fyr.bio

As we turn the page to a new year, we’re inspired by how far we’ve come & energized for what’s ahead. At FYR, we’re driven to push the boundaries of #PrecisionMedicine through bold #science and meaningful partnerships. Wishing everyone a healthy and happy New Year! ✨

Our bodies send signals, and FYR’s technology listens. Using extracellular vesicles and AI-enabled analytics, our EV-Omics platform decodes proteins and RNA in the blood to map disease activity. For more on the future of #PrecisionMedicine: fyr.bio/technology/ #TechTuesday

We’re excited to partner w/ NuvOx Therapeutics on their P2b #Glioblastoma trial, funded by an @theNCI grant. Using FYR’s EV-Omics platform, we’ll track #Tumor hypoxia & treatment response, advancing #Biomarker innovation in #Oncology. Connect with us to learn more: bd@fyr.bio.

This week, we’ll be @NeuroOnc #SNO2025 Annual Meeting! Excited to share our latest work on the proteomic fingerprints of malignant #glioma. 📌 Poster: Sex-associated Biomarker Signatures in Malignant Glioma: Insights from a Proteomics Study 🗓 Nov. 22, 11:45 am-1:05 pm HST

Heading to the @NeuroOnc Annual Meeting in Honolulu? We’ll be there! FYR is proud to join global leaders in #NeuroOncology to advance research, innovation and patient care. We’re committed to helping improve outcomes for patients. Hope to see you at #SNO2025!

This week, the FYR team will be onsite @OGConferences Biomarkers & Precision Medicine USA 2025 in SF! We’re proud to sponsor this premier event and showcase how our multiomic-based #biomarker platforms are advancing clinical development. Visit us at booth #9! #BPM2025

It’s #InternationalBrainTumorWeek and we stand with the global community to raise awareness and highlight the power of early detection. Through advancing protein-based blood tests, we’re driving innovation to improve outcomes for brain tumor patients. #IBTAWeek

The FYR team is gearing up for next week’s @OGConferences Biomarkers & Precision Medicine USA 2025. We’re excited to connect with attendees driving the future of #PrecisionMedicine. Booth #9 – see you in San Fran at #BPM2025!